Cytosis is the general term for any process in which a cell moves material in or out by wrapping it in a small bubble of membrane called a vesicle. When material enters the cell this way, the process is called endocytosis; when the cell pushes material out, it is exocytosis. Together, these two directions of traffic handle everything from absorbing nutrients and clearing cholesterol to releasing hormones and firing nerve signals. The concept sounds simple, but the variety of mechanisms cells use to pull off these feats, and the ways those mechanisms go wrong in disease, make cytosis one of the most active areas in cell biology.
Why Cells Need Vesicle Transport in the First Place
Every cell is surrounded by a membrane made of fatty molecules that acts like a security fence. Small, uncharged molecules such as oxygen and carbon dioxide can slip through on their own, and ions get shuttled through specialized protein channels. But many of the things a cell needs to take in or release are too large, too charged, or too complex to cross that barrier through any passive route. Proteins, lipid particles, whole bacteria, and even neighboring cells’ chemical messages all fall into this category. Cytosis solves the problem by deforming the membrane itself: bulging it inward to swallow something from outside, or fusing an internal vesicle with the membrane to dump cargo into the surrounding space.
This membrane-based transport is not optional. Without it, immune cells could not engulf invading bacteria, nerve cells could not communicate, and your body could not regulate blood sugar or cholesterol. Researchers have even proposed that the emergence of endocytosis was one of the key developments that made complex, eukaryotic cell organization possible in the first place.
1PubMed Central. Endocytosis and signaling: cell logistics shape the eukaryotic cell planThe Main Flavors of Endocytosis
Endocytosis is not a single mechanism. Cells have evolved several distinct ways to pull things inside, each suited to different kinds of cargo. The major categories are phagocytosis, pinocytosis and macropinocytosis, and receptor-mediated endocytosis. A handful of less well-known pathways round out the picture.
Phagocytosis
Phagocytosis is the “cell-eating” pathway, and it handles the largest cargo. Immune cells like macrophages and neutrophils use it to engulf bacteria, dead cells, and debris. When surface receptors on the immune cell recognize a target, the cell’s internal skeleton reorganizes in a series of stages: first, the stiff outer layer of the cytoskeleton loosens at the contact point; then new structural filaments push outward to form arm-like extensions (pseudopods) that wrap around the particle; finally, those extensions seal together to trap the particle inside a large internal compartment called a phagosome.
2PubMed. Phagocytosis: receptors, signal integration, and the cytoskeletonOnce sealed, the phagosome merges with compartments loaded with digestive enzymes and acidic conditions, breaking down whatever was captured. This is how your immune system destroys most bacterial invaders before they can establish an infection.
Pinocytosis and Macropinocytosis
If phagocytosis is cell-eating, pinocytosis is “cell-drinking.” Rather than engulfing a solid target, pinocytosis brings in small amounts of surrounding fluid along with whatever molecules happen to be dissolved in it. Virtually all cells do this constantly as a background activity.
Macropinocytosis is the large-scale version. It uses bursts of actin-driven membrane ruffling to capture big gulps of extracellular fluid in a non-selective way. Cancer cells are known to rely heavily on macropinocytosis to scavenge proteins and other nutrients from their environment, compensating for their high metabolic demands.
3PubMed. Macropinocytosis: Molecular mechanisms and regulation Immune cells also use it to sample the extracellular environment for fragments of foreign proteins, which they then present to other immune cells to coordinate a response.
4PubMed Central. Metabolic functions of macropinocytosisReceptor-Mediated Endocytosis
This is the most selective form of endocytosis, and the most heavily studied. Instead of grabbing whatever is nearby, the cell picks up specific molecules that latch onto matching receptors on its surface. In the most common version, the receptors cluster in specialized patches of membrane coated with a protein scaffold called clathrin. As cargo binds, the coated patch curves inward and eventually pinches off to form a small, coated vesicle inside the cell.
5PubMed Central. Regulation of Clathrin-Mediated EndocytosisClathrin-mediated endocytosis is the dominant uptake pathway in mammalian cells. It controls the intake of growth signals, nutrients like iron-carrying transferrin, and the clearance of cholesterol-carrying LDL particles from the blood. It also constantly remodels which receptors and transporters sit on the cell surface, giving the cell a way to adjust its responsiveness to its surroundings.
Clathrin-Independent Routes
Not all receptor-mediated uptake uses clathrin. Several alternative pathways operate through cholesterol-rich patches of the membrane known as lipid rafts. Caveolae, which are small flask-shaped indentations lined by a protein called caveolin, are the best-known example: they pinch off to carry certain viruses, toxins, and signaling molecules into the cell.
6PubMed. Lipid rafts, caveolae, and their endocytosis Beyond caveolae, there are at least several other clathrin-independent routes that researchers have identified, each relying on different molecular machinery.
7PubMed Central. Endocytosis of gene delivery vectors: from clathrin-dependent to lipid raft-mediated endocytosisWhy so many pathways? Part of the answer is that different cargo types have different physical properties, and different cell types face different challenges. But the redundancy also matters: if one route is blocked or overwhelmed, a cell can reroute traffic through another. That flexibility makes endocytosis remarkably resilient.
What Happens After Something Gets Inside
Swallowing material is only half the story. Once a vesicle pinches off from the outer membrane and enters the cell, it arrives at a compartment called an endosome. Endosomes serve as sorting stations, the cellular equivalent of a mail room. Here, the cell decides what to do with each piece of incoming cargo: should a receptor be sent back to the surface for reuse, forwarded deeper into the cell, or routed to a compartment that will break it down?
8PubMed Central. Advances and challenges in understanding endosomal sorting and fissionThat decision point matters enormously. A receptor that gets recycled back to the surface can pick up more cargo; one that gets degraded is gone. Cells use this sorting step to dial their own sensitivity up or down. For instance, if a cell is being flooded with a particular growth signal, it can divert the receptors for that signal toward degradation, turning down the volume. Endosomal sorting failures are implicated in diseases ranging from certain cancers to neurodegenerative conditions, because cargo that should be destroyed piles up, or receptors that should be recycled are lost.
Exocytosis and the Two Modes of Secretion
Exocytosis is the mirror image of endocytosis: an internal vesicle travels to the cell surface, fuses with the outer membrane, and releases its contents into the extracellular space. It comes in two basic flavors.
Constitutive exocytosis happens continuously in every cell. Proteins and lipids produced inside the cell are packaged into vesicles and shipped to the membrane as part of normal maintenance. This is how cells deliver new membrane components, release structural proteins for the tissue around them, and export waste.
Regulated exocytosis is more dramatic. Specialized cells stockpile cargo in vesicles and hold them at the ready until a trigger arrives, usually a rise in calcium concentration inside the cell.
9PubMed. Exocytosis When the signal hits, a burst of vesicles fuse with the membrane almost simultaneously. Neurons releasing neurotransmitters and pancreatic beta cells releasing insulin both rely on this on-demand version.
SNARE Proteins and How Membranes Actually Fuse
Getting two membranes to merge is surprisingly hard. Lipid bilayers naturally repel each other because of their electrical charges and surrounding water molecules. The cell solves this with a family of proteins called SNAREs. Complementary SNARE proteins on the vesicle and on the target membrane reach across the gap and “zipper” together, pulling the two membranes into close contact and eventually forcing them to merge.
10PubMed Central. Mechanisms of SNARE proteins in membrane fusionDetailed simulations of this process show that the zippering action pushes into the region where the membrane’s fatty tails face each other, creating a small hydrophobic seed where lipid molecules from both membranes mix. That seed expands rapidly into a structure called a stalk, which then opens into a full pore through which cargo can escape.
11PubMed Central. Molecular mechanism underlying SNARE-mediated membrane fusion enlightened by all-atom molecular dynamics simulations The whole process can happen on a microsecond timescale, which is critical for events like nerve signaling where speed is everything.
SNARE-mediated fusion is also how neurotransmitters are released at synapses. Synaptic vesicles loaded with chemical messengers sit docked at the nerve terminal, held in place by SNARE complexes that are primed and ready. When an electrical signal triggers a calcium influx, the SNAREs complete their zippering, the vesicle fuses, and the neurotransmitter spills into the gap between neurons.
12PubMed. Mechanisms of synaptic vesicle exocytosisHow Your Body Uses These Pathways Every Day
Cholesterol Management
One of the best-understood examples of receptor-mediated endocytosis in human health is LDL cholesterol clearance. LDL particles carrying cholesterol through the bloodstream bind to LDL receptors on liver cells, triggering clathrin-mediated uptake.
13PubMed Central. Receptor-mediated endocytosis: insights from the lipoprotein receptor system Inside the cell, the LDL is broken down and its cholesterol extracted for use or storage, while the receptor is recycled back to the surface to grab another particle.
When this recycling system works well, it keeps blood cholesterol in check. When it fails, cholesterol builds up. Disruption of LDL receptor recycling is a fundamental process underlying high blood cholesterol, a condition that affects a large portion of the population in Western countries.
14PubMed Central. Low-Density Lipoprotein Internalization, Degradation and Receptor Recycling Along Membrane Contact Sites The balance between receptor recycling and receptor degradation determines how many LDL receptors are active on the cell surface at any given time, and therefore how efficiently your body clears cholesterol.
15PubMed. Cholesterol in LDL receptor recycling and degradation Drugs like statins and newer PCSK9 inhibitors both work, in different ways, by increasing the number of functional LDL receptors on liver cells so that more cholesterol gets pulled out of circulation.
Insulin Release and Blood Sugar
Pancreatic beta cells are a textbook case of regulated exocytosis. These cells store insulin in dense-core vesicles and release it in response to rising blood glucose. After a meal, glucose enters the beta cell, triggers a chain of metabolic events that raises internal calcium, and that calcium signal causes insulin-packed vesicles to fuse with the cell surface and dump their contents into the bloodstream.
16PubMed. The ins and outs of secretion from pancreatic beta-cells: control of single-vesicle exo- and endocytosis Afterward, the spent vesicle membrane is recaptured through clathrin-mediated endocytosis, recycled, and reloaded with fresh insulin. Defects in any part of this cycle can contribute to impaired insulin secretion and, ultimately, diabetes.
Glucose Transporter Shuttling
Insulin’s effects on target tissues also depend on cytosis. Muscle and fat cells keep glucose transporter proteins stored inside in vesicles. When insulin arrives at the cell surface and binds its receptor, those transporter-bearing vesicles undergo regulated exocytosis, moving to the membrane and opening the door for glucose to enter.
17PubMed. Endocytosis, recycling, and regulated exocytosis of glucose transporter 4 When insulin levels drop, the transporters are pulled back inside by endocytosis. This cycling explains why insulin resistance at the vesicle-trafficking level can starve cells of glucose even when blood sugar is high.
How Pathogens Hijack the System
Many viruses have evolved to exploit the cell’s endocytic machinery as a front door. Rather than forcing their way through the membrane, they bind to cell-surface receptors and get carried inside through the same pathways the cell uses for normal cargo. Studies show that endocytosis is more often the preferred route of viral entry compared to direct fusion at the cell surface.
18PubMed Central. Virus entry paradigmsClathrin-mediated endocytosis and caveolae-mediated uptake are both well-characterized viral entry portals, and many viruses can use multiple pathways, making them harder to block. The protein dynamin, which pinches vesicles free from the membrane, plays a central role in several of these routes and has become a target of antiviral research.
19PubMed. From endocytosis to membrane fusion: emerging roles of dynamin in virus entry Once inside an endosome, the virus typically exploits the compartment’s dropping pH to trigger a shape change in its own proteins, allowing it to escape into the cell’s interior and begin replicating. Influenza is a classic example: it hitches a ride through clathrin-mediated endocytosis, then uses the acidic endosomal environment to pop open and release its genetic material.
Bacteria use cytosis too, but from the other direction. Some species actively trigger their own phagocytosis by non-immune cells, then survive inside the phagosome by blocking the digestive enzymes that would normally destroy them. Others inject proteins that reprogram the host cell’s vesicle traffic, rerouting nutrients toward the bacteria or preventing the phagosome from maturing.
Transcytosis and Moving Material Across Barriers
Sometimes a cell needs to move cargo not just inside but all the way through itself and out the other side. This combined process, called transcytosis, uses endocytosis on one face of the cell and exocytosis on the other. It is the strategy multicellular organisms use to shuttle material across tight cellular barriers without breaking those barriers open.
20PubMed. Transcytosis: crossing cellular barriersThe blood-brain barrier is one of the best-known examples. The cells lining brain blood vessels are locked together so tightly that almost nothing can pass between them. But certain proteins can be taken up on the blood-facing side of these cells by adsorptive endocytosis, routed through internal compartments, and released on the brain side without ever compromising the barrier’s integrity.
21PubMed Central. Transcytotic pathway for blood-borne protein through the blood-brain barrier Researchers working on brain-targeted drug delivery are intensely interested in exploiting this pathway, because it offers a way to sneak therapeutics past a barrier that blocks most conventional drugs.
Transcytosis also operates in the gut, where epithelial cells use clathrin-mediated uptake to grab immune antibodies and shuttle them across the lining. The process can be selective, using receptors, or non-selective, carrying whatever is dissolved in the fluid phase of the vesicle.
22Molecular Therapy. Adeno-Associated Virus Penetration of Polarized Epithelial and Endothelial Cell Barriers by TranscytosisDrug Delivery and Nanoparticle Design
Pharmaceutical researchers now routinely design drug carriers to exploit specific endocytic pathways. Nanoparticles and lipid-based carriers are engineered to enter cells through endocytosis, delivering chemotherapy agents, gene therapies, or RNA-based drugs directly to the cell interior.
23PubMed Central. Endocytosis: The Nanoparticle and Submicron Nanocompounds Gateway into the CellThe lipid nanoparticles used in mRNA vaccines are a high-profile example. Studies of these particles show they enter cells using both clathrin-mediated endocytosis and macropinocytosis, with the balance depending on cell type.
24PubMed. Image-based analysis of lipid nanoparticle-mediated siRNA delivery, intracellular trafficking and endosomal escape Once inside an endosome, the nanoparticle has to escape before the compartment matures and its cargo gets degraded. This “endosomal escape” step is one of the biggest bottlenecks in RNA-based therapeutics: only a small fraction of internalized nanoparticles manage to release their payload into the cell’s working interior. Much of modern nanoparticle engineering focuses on tweaking the lipid composition and surface chemistry to improve that escape rate.
Particle size, shape, and surface charge all influence which endocytic pathway a nanoparticle enters. Smaller particles tend to favor clathrin-mediated uptake, while larger ones may trigger macropinocytosis or even phagocytosis. By controlling these physical properties, designers can steer particles toward pathways that give the best chance of delivering their cargo to the right place inside the cell.
Exosomes and Cell-to-Cell Messaging
Cells do not just use exocytosis to dump waste or release hormones. They also release tiny vesicles called exosomes that carry proteins, lipids, and even snippets of RNA to other cells. Exosomes originate inside the endosomal system: as endosomes mature, they form small internal buds that accumulate cargo. When the mature endosome eventually fuses with the outer membrane through exocytosis, those internal buds are released into the extracellular space as exosomes.
25PubMed Central. The biology, function, and biomedical applications of exosomesReceiving cells then take up these exosomes through endocytosis, completing a communication loop that runs entirely on cytosis. This vesicle-based messaging system can transfer functional molecules over long distances through the bloodstream, and has been implicated in processes as diverse as immune regulation, tumor progression, and tissue repair. Researchers are exploring engineered exosomes as drug-delivery vehicles, since they are naturally biocompatible and can cross barriers that synthetic nanoparticles cannot.
Watching Vesicles in Real Time
One of the persistent challenges in studying cytosis is that vesicles are extremely small and events happen fast. A clathrin-coated pit forms, matures, and pinches off in roughly a minute, and a synaptic vesicle can fuse and release its contents in under a millisecond. For decades, much of what researchers knew came from snapshots taken with electron microscopy on fixed, dead cells.
That has changed with advances in live-cell imaging. New deep-learning tools can now detect, track, and classify individual endocytic and exocytic carriers in real time at roughly 100-nanometer resolution, using a specialized form of fluorescence microscopy.
26PubMed Central. Shape2Fate: a morphology-aware deep learning framework for tracking endocytic and exocytic carriers at nanoscale These approaches let researchers see not just where a vesicle goes, but how its shape changes along the way and whether it succeeds or fails at fusion. That kind of detail is revealing previously invisible steps in the process, including rare events and transient intermediate structures that were impossible to capture before.